News | Proton Therapy | July 29, 2015

Willis-Knighton Cancer Center Approaches First Anniversary With IBA’s Proteus One System

Cancer teams able to treat up to 20 patients per day with compact intensity modulated proton therapy system

IBA, Proteus One, compact proton therapy system, Willis-Knighton Cancer Center

July 29, 2015 — Teams at the Willis-Knighton Cancer Center in Shreveport, Louisiana, have achieved high levels of quality care, ease of use and speed of treatment in 11 months on IBA’s Proteus One compact proton therapy system.

After a record-setting 11 month installation with patient treatment beginning in September 2014, the Willis-Knighton team continues to set new records by employing a compact proton therapy system that treats clinically with pencil beam scanning (PBS). In addition to treating more common indications such as the brain and prostate, PBS has accelerated their ramp speed by enabling new applications such as breast, head and neck, esophageal lung, spine cancer, pediatric malignancies and various pelvis indications.

By working together with IBA, the Willis Knighton team is currently averaging 15 minutes per patient for most indications, even with multiple fields, resulting in a daily volume of 20 patients per eight-hour day. They expect that volume to increase based upon the even faster treatment times and expanded applications that Advanced Image Guidance with cone beam computed tomography (CBCT) will bring them. IBA’s Cone Beam CT is the only volumetric imaging solution to have obtained marketing authorization by the U.S. Food and Drug Administration (FDA) and is in clinical use daily.

Lane R. Rosen, M.D., director of radiation oncology at the Willis-Knighton Cancer Center, added: “The Proteus One has exceeded all of our expectations. We are very excited to have intensity modulated proton therapy and cone beam CT imaging available for our patients. Both Willis-Knighton and IBA teams have been partnering at each step to ensure a smooth transition from installation to first treatment and beyond during the ramp-up of operations. We have met or exceeded all of our expectations with this collaboration and are looking forward to even more treatment options for our patients in the future"

For more information: www.iba-worldwide.com

Related Content

Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.

News | Quality Assurance (QA) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer...
The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning

The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning. Image courtesy of Siemens Healthineers.

News | Computed Tomography (CT) | September 15, 2019
Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the...
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
News | Brachytherapy Systems | September 13, 2019
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the...
Akesis Galaxy SRS System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | September 13, 2019
The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has...
Philips Showcases Integrated Radiation Oncology Portfolio at ASTRO 2019
News | Radiation Oncology | September 13, 2019
Philips will showcase its integrated radiation oncology portfolio at the American Society of Radiation Oncology (ASTRO...
RefleXion Highlights Novel Approach to Radiotherapy at ASTRO 2019

The RefleXion X1 Machine without the Gantry Cover. The patented technology incorporates PET imaging data, which enables tumors to continuously signal their location. Image courtesy of Reflexion Medical.

News | Radiation Therapy | September 12, 2019
Therapeutic oncology company RefleXion Medical announced it will showcase the RefleXion X1 Machine at the American...
IBA Dosimetry Releases myQA Machines Software at ASTRO 2019
Technology | Quality Assurance (QA) | September 12, 2019
IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming...
ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian
News | Image Guided Radiation Therapy (IGRT) | September 11, 2019
ViewRay Inc. announced that the company's MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation...